M. Hussain et al., A 140-KILODALTON EXTRACELLULAR PROTEIN IS ESSENTIAL FOR THE ACCUMULATION OF STAPHYLOCOCCUS-EPIDERMIDIS STRAINS ON SURFACES, Infection and immunity, 65(2), 1997, pp. 519-524
Two distinct pathogenic mechanisms, adhesion to polymer surfaces and s
ubsequent accumulation of sessile bacterial cells, are considered impo
rtant pathogenic steps in foreign body infections caused by Staphyloco
ccus epidermidis, By using mitomycin mutagenesis, we have recently gen
erated a mutant, strain M7, from S. epidermidis RP62A which is unaffec
ted in adhesion but deficient in accumulation on glass or polystyrene
surfaces and lacks a 115-kDa extracellular protein (designated the 140
-kDa antigen; F. Schumacher-Perdreau, C. Heilmann, G. Peters, F. Gotz,
and G. Pulverer, FEMS Microbiol. Lett. 117:71-78, 1994), To evaluate
the role of this protein in accumulation, we harvested extracellular p
roteins from S. epidermidis RP62A grown on dialysis membranes placed o
ver chemically defined medium, purified the protein by using ion-excha
nge chromatography, determined its N-terminal amino acid sequence, and
raised antiserum in rabbits, The antibody recognized only a single ba
nd in a Western immunoblot of the crude extracellular extract, With th
e microtiter biofilm test, antiserum at a dilution of less than or equ
al to 1:1,000 blocked accumulation of RP62A up to 98% whereas preimmun
e serum did not, The 140-kDa antigen was found only in extracellular p
roducts from bacteria grown under sessile conditions, Of 58 coagulase-
negative clinical isolates, 32 strains were 140-kDa antigen positive a
nd produced significantly larger amounts of biofilm than the 26 strain
s that were 140-kDa antigen negative, The 140-kDa protein appears to b
e biochemically and functionally unrelated to any previously described
factors associated with biofilm formation, Thus, the 140-kDa antigen,
referred to as accumulation-associated protein, may be a factor essen
tial in S. epidermidis accumulation and, due to its immunogenicity, ma
y allow the development of novel immunotherapeutic strategies for prev
ention of foreign body infection.